Electrophysiological effects of SD-3212, a novel antiarrhythmic agent, on rabbit hearts in vivo and in vitro

Naohiko Takahashi, Morio Ito, Shuji Ishida, Takao Fujino, Toru Maruyama, Tetsunori Saikawa

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We examined the electrophysiological effects of SD-3212, a novel antiarrhythmic agent in rabbits in in vivo and in vitro experiments. During in vivo experiments, monophasic action potentials (MAPs) of the left ventricular endocardium were simultaneously recorded with surface ECG and arterial blood pressure (BP). Under constant atrial pacing, SD-3212 (0.1, 0.2, and 0.3 mg/kg/min) was continuously infused in rabbits for 20 min. SD-3212 3 ±0.2 mg/kg/min prolonged PQ interval, QRS duration, and MAP duration, and decreased arterial BP dose dependently. During in vitro experiments, transmembrane APs were recorded from the isolated papillary muscles by a microelectrode technique. SD-3212 (3 χ 10-6-10-5M) prolonged the AP duration (APD) and decreased the maximum upstroke velocity of the AP (Vmax) in a concentration-dependent manner without affecting the amplitude of AP or resting potential. The inhibitory action of SD-3212 on Vmax was enhanced as the stimulation frequency was increased, whereas the prolongation of APD did not vary with stimulation frequency. The results suggest that SD-3212 has an inhibitory action on some outward currents as well as sodium and calcium currents.

Original languageEnglish
Pages (from-to)1006-1011
Number of pages6
JournalJournal of Cardiovascular Pharmacology
Volume25
Issue number6
DOIs
Publication statusPublished - Jan 1995

Fingerprint

Rabbits
Action Potentials
Arterial Pressure
Endocardium
Papillary Muscles
Microelectrodes
Membrane Potentials
In Vitro Techniques
sesamodil
Electrocardiography
Sodium
Calcium

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this

Electrophysiological effects of SD-3212, a novel antiarrhythmic agent, on rabbit hearts in vivo and in vitro. / Takahashi, Naohiko; Ito, Morio; Ishida, Shuji; Fujino, Takao; Maruyama, Toru; Saikawa, Tetsunori.

In: Journal of Cardiovascular Pharmacology, Vol. 25, No. 6, 01.1995, p. 1006-1011.

Research output: Contribution to journalArticle

Takahashi, Naohiko ; Ito, Morio ; Ishida, Shuji ; Fujino, Takao ; Maruyama, Toru ; Saikawa, Tetsunori. / Electrophysiological effects of SD-3212, a novel antiarrhythmic agent, on rabbit hearts in vivo and in vitro. In: Journal of Cardiovascular Pharmacology. 1995 ; Vol. 25, No. 6. pp. 1006-1011.
@article{c9f2b985e17b41e7bfd6b2d3c380e1fb,
title = "Electrophysiological effects of SD-3212, a novel antiarrhythmic agent, on rabbit hearts in vivo and in vitro",
abstract = "We examined the electrophysiological effects of SD-3212, a novel antiarrhythmic agent in rabbits in in vivo and in vitro experiments. During in vivo experiments, monophasic action potentials (MAPs) of the left ventricular endocardium were simultaneously recorded with surface ECG and arterial blood pressure (BP). Under constant atrial pacing, SD-3212 (0.1, 0.2, and 0.3 mg/kg/min) was continuously infused in rabbits for 20 min. SD-3212 3 ±0.2 mg/kg/min prolonged PQ interval, QRS duration, and MAP duration, and decreased arterial BP dose dependently. During in vitro experiments, transmembrane APs were recorded from the isolated papillary muscles by a microelectrode technique. SD-3212 (3 χ 10-6-10-5M) prolonged the AP duration (APD) and decreased the maximum upstroke velocity of the AP (Vmax) in a concentration-dependent manner without affecting the amplitude of AP or resting potential. The inhibitory action of SD-3212 on Vmax was enhanced as the stimulation frequency was increased, whereas the prolongation of APD did not vary with stimulation frequency. The results suggest that SD-3212 has an inhibitory action on some outward currents as well as sodium and calcium currents.",
author = "Naohiko Takahashi and Morio Ito and Shuji Ishida and Takao Fujino and Toru Maruyama and Tetsunori Saikawa",
year = "1995",
month = "1",
doi = "10.1097/00005344-199506000-00022",
language = "English",
volume = "25",
pages = "1006--1011",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Electrophysiological effects of SD-3212, a novel antiarrhythmic agent, on rabbit hearts in vivo and in vitro

AU - Takahashi, Naohiko

AU - Ito, Morio

AU - Ishida, Shuji

AU - Fujino, Takao

AU - Maruyama, Toru

AU - Saikawa, Tetsunori

PY - 1995/1

Y1 - 1995/1

N2 - We examined the electrophysiological effects of SD-3212, a novel antiarrhythmic agent in rabbits in in vivo and in vitro experiments. During in vivo experiments, monophasic action potentials (MAPs) of the left ventricular endocardium were simultaneously recorded with surface ECG and arterial blood pressure (BP). Under constant atrial pacing, SD-3212 (0.1, 0.2, and 0.3 mg/kg/min) was continuously infused in rabbits for 20 min. SD-3212 3 ±0.2 mg/kg/min prolonged PQ interval, QRS duration, and MAP duration, and decreased arterial BP dose dependently. During in vitro experiments, transmembrane APs were recorded from the isolated papillary muscles by a microelectrode technique. SD-3212 (3 χ 10-6-10-5M) prolonged the AP duration (APD) and decreased the maximum upstroke velocity of the AP (Vmax) in a concentration-dependent manner without affecting the amplitude of AP or resting potential. The inhibitory action of SD-3212 on Vmax was enhanced as the stimulation frequency was increased, whereas the prolongation of APD did not vary with stimulation frequency. The results suggest that SD-3212 has an inhibitory action on some outward currents as well as sodium and calcium currents.

AB - We examined the electrophysiological effects of SD-3212, a novel antiarrhythmic agent in rabbits in in vivo and in vitro experiments. During in vivo experiments, monophasic action potentials (MAPs) of the left ventricular endocardium were simultaneously recorded with surface ECG and arterial blood pressure (BP). Under constant atrial pacing, SD-3212 (0.1, 0.2, and 0.3 mg/kg/min) was continuously infused in rabbits for 20 min. SD-3212 3 ±0.2 mg/kg/min prolonged PQ interval, QRS duration, and MAP duration, and decreased arterial BP dose dependently. During in vitro experiments, transmembrane APs were recorded from the isolated papillary muscles by a microelectrode technique. SD-3212 (3 χ 10-6-10-5M) prolonged the AP duration (APD) and decreased the maximum upstroke velocity of the AP (Vmax) in a concentration-dependent manner without affecting the amplitude of AP or resting potential. The inhibitory action of SD-3212 on Vmax was enhanced as the stimulation frequency was increased, whereas the prolongation of APD did not vary with stimulation frequency. The results suggest that SD-3212 has an inhibitory action on some outward currents as well as sodium and calcium currents.

UR - http://www.scopus.com/inward/record.url?scp=0029002244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029002244&partnerID=8YFLogxK

U2 - 10.1097/00005344-199506000-00022

DO - 10.1097/00005344-199506000-00022

M3 - Article

C2 - 7564327

AN - SCOPUS:0029002244

VL - 25

SP - 1006

EP - 1011

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - 6

ER -